End-of-day quote
Other stock markets
|
||
- USD | - |
Mar. 28 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | Top Midday Gainers | MT |
Financials (USD)
Sales 2024 * | 59.17M | Sales 2025 * | 88.09M | Capitalization | 29.1M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 11M | EV / Sales 2024 * | 0.49 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.33 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
6.59
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.99% |
1st Jan change | Capi. | |
---|---|---|
+27.97% | 672B | |
+23.88% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.04% | 211B | |
-0.51% | 203B | |
-10.35% | 194B | |
-11.81% | 144B |